Dr. Reddy's Laboratories
Search results
5 days ago · Biocon develops affordable biosimilars, generic formulations and complex APIs for global markets. It also offers research services and novel biologics for various diseases.
- Careers
Careers - Biocon - India's largest biopharmaceutical company
- Contact Us
Biocon Limited 20th KM, Hosur Road, Electronic City,...
- Products
Biocon is addressing global medical needs through a...
- About Us
About Us - Biocon - India's largest biopharmaceutical...
- Investor Relations
Biocon is a unique global biopharmaceutical company changing...
- Responsibility
Biocon academy, is a premier center of excellence for...
- News
News - Biocon - India's largest biopharmaceutical company
- Key Therapeutic Areas
At Biocon, our focus is on the three key therapeutic areas –...
- Careers
1 day ago · Get the latest Biocon share price, stock performance, financials, news, analysis and recommendations from Economic Times. Biocon is a leading Indian biopharmaceutical company with a market cap of Rs 36,726.35 crore as of 18 May, 2024.
- As on 05 Jan, 2024, 04:04 PM IST Biocon share price was up by 2.71% basis the previous closing price of Rs 282.35. Biocon share price was Rs 291.30...
- Biocon share price saw a 52 week high of Rs 294.50 and 52 week low of Rs 191.55.
- Biocon share has a market capitalization of Rs 34,973.48 Cr. Within Pharmaceuticals sector, it's market cap rank is 13.
- Following are the key changes to Biocon shareholding: Promoter holding has not changed in last 9 months and holds 60.64 stake as on 30 Sep 2023 Dom...
- Key Metrics for Biocon are: PE Ratio of Biocon is 70.17 Earning per share of Biocon is 4.15 Price/Sales ratio of Biocon is 2.22 Price to Book ratio...
- Top 10 Peers for Biocon are Gland Pharma Ltd., Syngene International Ltd., Ipca Laboratories Ltd., Ajanta Pharma Ltd., J B Chemicals & Pharmaceutic...
5 days ago · Biocon Biologics Ltd (BBL), a global, fully integrated biosimilars company and a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), has received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab at its new, world-class, multi-product monoclonal antibodies (mAbs) drug substance facility at Bengaluru.
5 days ago · Biocon Limited Stock Price Today, Live NSE Share Price: Get the latest Biocon Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Jun 20, 2024 · India's Biocon is seeking a Chinese partner to conduct clinical trials on generic versions of Novo Nordisk's popular diabetes drug Ozempic and weight loss treatment Wegovy. Biocon aims to eventually launch these generics globally, with plans to find a partner for the trials on over 500 patients in China, citing the substantial investment required.
4 days ago · Biocon Biologics, a global biosimilars company and a subsidiary of Biocon Ltd has received approval from European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab, a type of targeted ...
Jun 20, 2024 · Biocon aims to eventually launch these generics globally, with plans to find a partner for the trials on over 500 patients in China, citing the substantial investment required. The move comes ahead of the patent protection expiry on key ingredients in the drugs in 2026.
People also ask
What does Biocon do?
Who is Biocon Limited?
Is Biocon a good company?
Is Biocon Biologics a biosimilar company?
Where is Biocon located?
Will Biocon find a Chinese partner for Ozempic & wegovy?
